Chris Clark is the founder of Neovasc. Latest round: IPO. Backed by Shockwave Medical. Based in Richmond, Canada.
Chris Clark is the Chief Financial Officer at Neovasc, a medical company that develops devices for the treatment of refractory angina, such as the Reducer. Under his financial leadership, Neovasc has achieved significant revenue growth and strategic partnerships. Clark played a crucial role in securing critical financings and increasing the company's market capitalization. He joined Neovasc in 2007, bringing with him 20 years of finance and accounting experience.
Full founder directory · Investor directory · Company funding database · Fundraising library